Stereotaxis (STXS) Receivables - Other (2010 - 2019)
Stereotaxis' (STXS) quarterly Receivables - Other came in at $168445.0 in Q4 2019, down 33.12% year-over-year from $251867.0 in Q4 2018, and down 33.12% quarter-over-quarter from $251867.0 in Q4 2018.
Powered by 
Analysis
Stereotaxis (STXS) Receivables - Other (2010 - 2019) Analysis & Trends
Stereotaxis (STXS) has reported Receivables - Other for 7 consecutive years, with $168445.0 the latest figure, recorded in Q4 2019.
- On a quarterly basis, Receivables - Other fell 33.12% year-over-year to $168445.0 in Q4 2019; TTM through Dec 2019 was $168445.0, a 33.12% decrease from a year earlier, with the FY2019 full-year figure at $168445.0, down 33.12% from the prior year.
- Receivables - Other was $168445.0 for Q4 2019 at Stereotaxis, down from $251867.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $251867.0 in Q4 2018 and troughed at $168445.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 168,445.00 |
| Dec 31, 2018 | 251,867.00 |
| Mar 31, 2014 | -21,305.00 |
| Dec 31, 2013 | 695.00 |
| Sep 30, 2013 | 695.00 |
| Jun 30, 2013 | 847.00 |
| Mar 31, 2013 | -54,064.00 |
| Dec 31, 2012 | -1,624.00 |
| Sep 30, 2012 | 1,388.00 |
| Jun 30, 2012 | 1,344.00 |
| Mar 31, 2012 | -20,642.00 |
| Dec 31, 2011 | -34,214.00 |
| Sep 30, 2011 | 1,784.00 |
| Jun 30, 2011 | 1,931.00 |
| Mar 31, 2011 | 2,004.00 |
| Dec 31, 2010 | -60,579.00 |
| Sep 30, 2010 | -9,580.00 |